Both LDHA and LDHB were associated with tumor immune infiltrates in ccRCC patients, which suggested LDHA/LDHB could be implicated in the tumorigenesis of ccRCC and might be potential therapeutic targets for patients with ccRCC. Here, LDHA is linked to nonpapillary renal cell carcinoma.